Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,537
datasets available to search
ShareScore release 0.9.0
Dataset results
8,537 results for “Openness”
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT04445519. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
ClinicalTrials.gov study NCT00490568. IPD Sharing: Not stated. Countries: 29. Publications: 1.
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00287118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Closed Loop Isoflurane Administration With Bispectral Index in Open Heart Surgery
ClinicalTrials.gov study NCT01069562. IPD Sharing: Not stated. Countries: 1. Publications: 5.
An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
ClinicalTrials.gov study NCT00327470. IPD Sharing: Not stated. Countries: 15. Publications: 1.
IINB vs. QLB for Elective Open Inguinal Herniorrhaphy
ClinicalTrials.gov study NCT03007966. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
ClinicalTrials.gov study NCT01224210. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
ClinicalTrials.gov study NCT04099641. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
ClinicalTrials.gov study NCT02751931. IPD Sharing: YES. Countries: 19. Publications: 1.
An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System
ClinicalTrials.gov study NCT04198012. IPD Sharing: NO. Countries: 1. Publications: 5.
Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension
ClinicalTrials.gov study NCT03948178. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular H
ClinicalTrials.gov study NCT04620135. IPD Sharing: NO. Countries: 1. Publications: 1.
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
ClinicalTrials.gov study NCT02403323. IPD Sharing: Not stated. Countries: 33. Publications: 1.
MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
ClinicalTrials.gov study NCT03193736. IPD Sharing: NO. Countries: 2. Publications: 1.
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT01241240. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open
ClinicalTrials.gov study NCT00605280. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
ClinicalTrials.gov study NCT01905683. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT00509899. IPD Sharing: Not stated. Countries: 1. Publications: 3.
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
ClinicalTrials.gov study NCT02143843. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor The
ClinicalTrials.gov study NCT02141282. IPD Sharing: YES. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.